SEQSTER Launches 1-Click DataLake™ to Accelerate Clinical Trial Design, Recruitment, and Evidence Generation

SAN DIEGO--(BUSINESS WIRE)--SEQSTER PDM, Inc. (“SEQSTER”), the leading healthcare technology company and the data connection, collection, and orchestration layer for patient health data, today announced the launch of its 1-Click DataLake™, the real world data (RWD) platform accelerating study design, recruitment, and evidence generation for life sciences and healthcare.

“With longitudinal, research-ready data from 150M+ patients, we’re now providing a turnkey real world data infrastructure that accelerates study design, optimizes patient recruitment, and enables evidence generation," said Ardy Arianpour, CEO & Co-Founder

Share

Built on more than a decade of aggregated electronic health record (EHR) data, 1-Click DataLake™ provides access to real-world data from more than 150 million de-identified patients and 200,000 clinicians nationwide. The platform securely queries patient-consented records to deliver real-time, longitudinal visibility into patient journeys. These insights support advanced analytics and real-world evidence (RWE) generation to inform trial design, feasibility, and execution.

“We are turning health data into medicine for our clients,” said Ardy Arianpour, CEO & Co-Founder of SEQSTER. “With longitudinal, research-ready data from 150M+ patients, we’re now providing a turnkey real world data infrastructure that accelerates study design, optimizes patient recruitment, and enables evidence generation. By rapidly unlocking insights directly from real clinical encounters, our platform delivers a step-change in speed, scale, and intelligence across the clinical research lifecycle.”

SEQSTER’s queryable platform spans a broad range of practices and specialties and includes deep integration with diverse and historically underserved populations. This capability directly supports recent FDA mandates promoting diversity in clinical trials, helping sponsors ensure that studies better reflect the populations they intend to serve. The platform includes robust patient populations across a wide range of therapeutic areas, enabling precise cohort identification and more effective recruitment strategies.

SEQSTER is showcasing its 1-Click DataLake™ today at the Precision Medicine World Conference 2026 as part of the event's AI and Data Sciences Showcase, where leading AI companies will present on the newest technologies transforming drug development, clinical research, and patient care.

For more information on SEQSTER and its 1-Click DataLake™, please visit www.seqster.com.

ABOUT SEQSTER

SEQSTER is the leading healthcare technology company that connects, collects, and refines patient-consented health data across care settings into a unified, longitudinal patient view.

With 150M+ patients in its regulatory-grade platform, life sciences companies can accelerate research, AI developers can train higher-quality models, and patients can gain meaningful insights to better manage their health, all from consented, standardized health data.

Founded in 2016, SEQSTER is shaping a new era in healthcare by connecting patients, data, and AI to enable faster, smarter, and more trustworthy clinical and research decisions.

Learn more: info@seqster.com | www.seqster.com